India
· Delayed Price · Currency is INR Procter & Gamble Health Statistics
Total Valuation
Procter & Gamble Health has a market cap or net worth of INR 86.76 billion. The enterprise value is 84.41 billion.
| Market Cap | 86.76B |
| Enterprise Value | 84.41B |
Important Dates
The next estimated earnings date is Monday, November 4, 2024.
| Earnings Date | Nov 4, 2024 |
| Ex-Dividend Date | Nov 28, 2024 |
Share Statistics
Procter & Gamble Health has 16.60 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Shares Outstanding | 16.60M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | -0.19% |
| Owned by Insiders (%) | 0.04% |
| Owned by Institutions (%) | 20.43% |
| Float | 7.86M |
Valuation Ratios
The trailing PE ratio is 43.17.
| PE Ratio | 43.17 |
| Forward PE | n/a |
| PS Ratio | 7.54 |
| PB Ratio | 16.12 |
| P/FCF Ratio | 42.00 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 27.46, with an EV/FCF ratio of 40.87.
| EV / Earnings | 42.00 |
| EV / Sales | 7.33 |
| EV / EBITDA | 27.46 |
| EV / EBIT | 30.14 |
| EV / FCF | 40.87 |
Financial Position
The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.02.
| Current Ratio | 2.39 |
| Quick Ratio | 1.57 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.03 |
| Debt / FCF | 0.05 |
| Interest Coverage | 388.94 |
Financial Efficiency
Return on equity (ROE) is 31.18% and return on invested capital (ROIC) is 26.71%.
| Return on Equity (ROE) | 31.18% |
| Return on Assets (ROA) | 18.47% |
| Return on Capital (ROIC) | 26.71% |
| Revenue Per Employee | 8.18M |
| Profits Per Employee | 1.43M |
| Employee Count | 1,407 |
| Asset Turnover | 1.21 |
| Inventory Turnover | 2.71 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.84% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +2.84% |
| 50-Day Moving Average | 5,256.74 |
| 200-Day Moving Average | 5,061.35 |
| Relative Strength Index (RSI) | 46.40 |
| Average Volume (20 Days) | 747 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Procter & Gamble Health had revenue of INR 11.51 billion and earned 2.01 billion in profits. Earnings per share was 121.07.
| Revenue | 11.51B |
| Gross Profit | 8.21B |
| Operating Income | 2.80B |
| Pretax Income | 2.73B |
| Net Income | 2.01B |
| EBITDA | 3.07B |
| EBIT | 2.80B |
| Earnings Per Share (EPS) | 121.07 |
Balance Sheet
The company has 2.44 billion in cash and 95.60 million in debt, giving a net cash position of 2.35 billion or 141.45 per share.
| Cash & Cash Equivalents | 2.44B |
| Total Debt | 95.60M |
| Net Cash | 2.35B |
| Net Cash Per Share | 141.45 |
| Equity (Book Value) | 5.38B |
| Book Value Per Share | 324.29 |
| Working Capital | 3.05B |
Cash Flow
In the last 12 months, operating cash flow was 2.28 billion and capital expenditures -217.30 million, giving a free cash flow of 2.07 billion.
| Operating Cash Flow | 2.28B |
| Capital Expenditures | -217.30M |
| Free Cash Flow | 2.07B |
| FCF Per Share | 124.43 |
Margins
Gross margin is 71.29%, with operating and profit margins of 24.32% and 17.46%.
| Gross Margin | 71.29% |
| Operating Margin | 24.32% |
| Pretax Margin | 23.74% |
| Profit Margin | 17.46% |
| EBITDA Margin | 26.70% |
| EBIT Margin | 24.32% |
| FCF Margin | 17.94% |
Dividends & Yields
This stock pays an annual dividend of 120.00, which amounts to a dividend yield of 2.30%.
| Dividend Per Share | 120.00 |
| Dividend Yield | 2.30% |
| Dividend Growth (YoY) | 342.48% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 206.48% |
| Buyback Yield | -0.01% |
| Shareholder Yield | 2.29% |
| Earnings Yield | 2.32% |
| FCF Yield | 2.38% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |